Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
24
Number of overlapping holdings
17.6%
% of XBI's 136 holdings also in HELX
42.9%
% of HELX's 62 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus HELX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in HELX |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 3.5% | 3.1% | 3.1% |
|
VERTEX PHARMACEUTICALS INC | 2.6% | 5.6% | 2.6% |
|
INSMED INC | 2.6% | 2.1% | 2.1% |
|
SAREPTA THERAPEUTICS INC | 2.7% | 1.8% | 1.8% |
|
REGENERON PHARMACEUTICALS | 1.7% | 5.3% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to HELX
|
GILEAD SCIENCES INC | 3.0% |
|
INCYTE CORP | 2.9% |
|
ADVENTRX PHARMACEUTICALS INC | 2.8% |
|
ABBVIE INC | 2.4% |
|
AMGEN INC | 2.2% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.2% |
|
BIOMARIN PHARMACEUTICAL INC | 2.1% |
|
BIOGEN IDEC INC | 2.1% |
|
VIKING THERAPEUTICS, INC. | 1.9% |
|
NEUROCRINE BIOSCIENCES INC | 1.8% |
XBI Underweight Relative to HELX
|
MEDPACE HOLDINGS, INC. | -6.4% |
|
DANAHER CORP | -5.2% |
|
THERMO FISHER SCIENTIFIC INC | -4.9% |
|
ELI LILLY & CO | -4.2% |
|
KRYSTAL BIOTECH, INC. | -3.8% |
|
REGENERON PHARMACEUTICALS | -3.6% |
 |
SAMSUNG BIOLOGICS CO., LTD. | -3.3% |
|
VERTEX PHARMACEUTICALS INC | -3.0% |
 |
ASTRAZENECA PLC-SPONS ADR | -2.6% |
|
BRUKER CORP | -2.4% |